Isoform A of Lactate Dehydrogenase (LDH-A), a potential ultra-early, high sensitivity biomarker of tumorigenesis.
Published in October 2020 Issue 10 (Vol. 7, Issue 10, 2020)

Abstract
Citations & discovery
Explore citations to this article and find it in scholarly databases.
Checking citation sources…
Citation counts reflect each source's coverage. Europe PMC shows DOI search matches, including mentions in references. Article lists may be incomplete. Google Scholar opens a separate search.
Authors (2)
Ernesto Prieto Gratacós
Precision Metabolic Oncology U...Precision Metabolic Oncology UKPrecision Metabolic Oncology UKPrecision Metabolic Oncology UK
View all publications →Pablo Aguirre Gauto
Metabolic Therapy Center of Bu...Metabolic Therapy Center of Buenos AiresMetabolic Therapy Center of Buenos AiresMetabolic Therapy Center of Buenos Aires
View all publications →Download Article
Summarise this paper with AI:
Article Information
Published in:
October 2020 Issue 10 (Vol. 7, Issue 10, 2020)Article Impact
Smart Citations
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
How to Cite
Prieto Gratacós, E., & Aguirre Gauto, P. (2020). Isoform A of Lactate Dehydrogenase (LDH-A), a potential ultra-early, high sensitivity biomarker of tumorigenesis.. British Journal of Medical and Health Research, 7(10), 1-13. https://doi.org/10.46624/bjmhr.2020.v7.i10.002
Article Actions
More from this Issue
Dental health concerns in pregnancy: Need for a collaborative management approach
More by These Authors
Bone Changes Assessment In Screw-Retained Maxillary Implant Supported Complete Denture With Electric Welded Metal Framwor Versus Casted Framework(RCT, Split Mouth Trial)
2023 • Vol. 10, Issue 5
Read more →
